BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 34481846)

  • 1. Single-Cell DNA Sequencing Reveals Punctuated and Gradual Clonal Evolution in Hepatocellular Carcinoma.
    Guo L; Yi X; Chen L; Zhang T; Guo H; Chen Z; Cheng J; Cao Q; Liu H; Hou C; Qi L; Zhu Z; Liu Y; Kong R; Zhang C; Zhou X; Zhang Z; Song T; Xue R; Zhang N
    Gastroenterology; 2022 Jan; 162(1):238-252. PubMed ID: 34481846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comprehensive genome-wide analysis of long noncoding RNA expression profile in hepatocellular carcinoma.
    Cui H; Zhang Y; Zhang Q; Chen W; Zhao H; Liang J
    Cancer Med; 2017 Dec; 6(12):2932-2941. PubMed ID: 29047230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma.
    Nagasue N; Kohno H; Hayashi T; Yamanoi A; Uchida M; Takemoto Y; Makino Y; Ono T; Hayashi J; Nakamura T
    Gastroenterology; 1993 Nov; 105(5):1449-54. PubMed ID: 8224647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel insights into breast cancer copy number genetic heterogeneity revealed by single-cell genome sequencing.
    Baslan T; Kendall J; Volyanskyy K; McNamara K; Cox H; D'Italia S; Ambrosio F; Riggs M; Rodgers L; Leotta A; Song J; Mao Y; Wu J; Shah R; Gularte-Mérida R; Chadalavada K; Nanjangud G; Varadan V; Gordon A; Curtis C; Krasnitz A; Dimitrova N; Harris L; Wigler M; Hicks J
    Elife; 2020 May; 9():. PubMed ID: 32401198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverse modes of clonal evolution in HBV-related hepatocellular carcinoma revealed by single-cell genome sequencing.
    Duan M; Hao J; Cui S; Worthley DL; Zhang S; Wang Z; Shi J; Liu L; Wang X; Ke A; Cao Y; Xi R; Zhang X; Zhou J; Fan J; Li C; Gao Q
    Cell Res; 2018 Mar; 28(3):359-373. PubMed ID: 29327728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable Intra-Tumor Genomic Heterogeneity of Multiple Lesions in Patients With Hepatocellular Carcinoma.
    Xue R; Li R; Guo H; Guo L; Su Z; Ni X; Qi L; Zhang T; Li Q; Zhang Z; Xie XS; Bai F; Zhang N
    Gastroenterology; 2016 Apr; 150(4):998-1008. PubMed ID: 26752112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiregional whole-genome sequencing of hepatocellular carcinoma with nodule-in-nodule appearance reveals stepwise cancer evolution.
    Takeda H; Takai A; Kumagai K; Iguchi E; Arasawa S; Eso Y; Shimizu T; Ueda Y; Taura K; Uemoto S; Kita R; Haga H; Marusawa H; Fujimoto A; Seno H
    J Pathol; 2020 Dec; 252(4):398-410. PubMed ID: 32815153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents.
    Gao Q; Wang ZC; Duan M; Lin YH; Zhou XY; Worthley DL; Wang XY; Niu G; Xia Y; Deng M; Liu LZ; Shi JY; Yang LX; Zhang S; Ding ZB; Zhou J; Liang CM; Cao Y; Xiong L; Xi R; Shi YY; Fan J
    Gastroenterology; 2017 Jan; 152(1):232-242.e4. PubMed ID: 27639803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas.
    Ding X; He M; Chan AWH; Song QX; Sze SC; Chen H; Man MKH; Man K; Chan SL; Lai PBS; Wang X; Wong N
    Gastroenterology; 2019 Dec; 157(6):1630-1645.e6. PubMed ID: 31560893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and transcriptional heterogeneity of multifocal hepatocellular carcinoma.
    Xu LX; He MH; Dai ZH; Yu J; Wang JG; Li XC; Jiang BB; Ke ZF; Su TH; Peng ZW; Guo Y; Chen ZB; Chen SL; Peng S; Kuang M
    Ann Oncol; 2019 Jun; 30(6):990-997. PubMed ID: 30916311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ALK gene copy number gain and its clinical significance in hepatocellular carcinoma.
    Jia SW; Fu S; Wang F; Shao Q; Huang HB; Shao JY
    World J Gastroenterol; 2014 Jan; 20(1):183-92. PubMed ID: 24415871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratumoral heterogeneity and clonal evolution in liver cancer.
    Losic B; Craig AJ; Villacorta-Martin C; Martins-Filho SN; Akers N; Chen X; Ahsen ME; von Felden J; Labgaa I; DʹAvola D; Allette K; Lira SA; Furtado GC; Garcia-Lezana T; Restrepo P; Stueck A; Ward SC; Fiel MI; Hiotis SP; Gunasekaran G; Sia D; Schadt EE; Sebra R; Schwartz M; Llovet JM; Thung S; Stolovitzky G; Villanueva A
    Nat Commun; 2020 Jan; 11(1):291. PubMed ID: 31941899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bidirectional deep neural networks to integrate RNA and DNA data for predicting outcome for patients with hepatocellular carcinoma.
    Huang G; Wang C; Fu X
    Future Oncol; 2021 Nov; 17(33):4481-4495. PubMed ID: 34374301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic structures of dysplastic nodule and concurrent hepatocellular carcinoma.
    Lee M; Kim K; Kim SY; Jung SH; Yoon J; Kim MS; Park HC; Jung ES; Chung YJ; Lee SH
    Hum Pathol; 2018 Nov; 81():37-46. PubMed ID: 29949741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A microRNA biomarker of hepatocellular carcinoma recurrence following liver transplantation accounting for within-patient heterogeneity.
    Xie QY; Almudevar A; Whitney-Miller CL; Barry CT; McCall MN
    BMC Med Genomics; 2016 Apr; 9():18. PubMed ID: 27059462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up.
    Cho HJ; Kim SS; Wang HJ; Kim BW; Cho H; Jung J; Cho SS; Kim JK; Lee JH; Kim YB; Yang MJ; Yoo BM; Lee KJ; Cho SW; Cheong JY
    DNA Cell Biol; 2016 Feb; 35(2):71-80. PubMed ID: 26624274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy pattern in synchronous and metachronous hepatocellular carcinomas.
    Nagasue N; Kohno H; Chang YC; Yamanoi A; Kimoto T; Takemoto Y; Nakamura T
    J Hepatol; 1992 Sep; 16(1-2):208-14. PubMed ID: 1336508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inferring the progression of multifocal liver cancer from spatial and temporal genomic heterogeneity.
    Shi JY; Xing Q; Duan M; Wang ZC; Yang LX; Zhao YJ; Wang XY; Liu Y; Deng M; Ding ZB; Ke AW; Zhou J; Fan J; Cao Y; Wang J; Xi R; Gao Q
    Oncotarget; 2016 Jan; 7(3):2867-77. PubMed ID: 26672766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of prognostic biomarkers of hepatocellular carcinoma via long noncoding RNA expression and copy number alterations.
    Du W; Chen W; Shu Z; Xiang D; Bi K; Lu Y; Zhang X; Li L; Diao H
    Epigenomics; 2020 Aug; 12(15):1303-1315. PubMed ID: 32772564
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
    Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
    World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.